Next Article in Journal
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
Next Article in Special Issue
The COVID-19 Vaccine Is Here—Now Who Is Willing to Get It?
Previous Article in Journal
Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
Previous Article in Special Issue
Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing
 
 
Article

Article Versions Notes

Vaccines 2021, 9(4), 330; https://doi.org/10.3390/vaccines9040330
Action Date Notes Link
article xml file uploaded 1 April 2021 09:16 CEST Original file -
article xml uploaded. 1 April 2021 09:16 CEST Update -
article pdf uploaded. 1 April 2021 09:16 CEST Version of Record -
article html file updated 1 April 2021 09:17 CEST Original file -
article xml file uploaded 1 April 2021 09:43 CEST Update -
article xml uploaded. 1 April 2021 09:43 CEST Update -
article pdf uploaded. 1 April 2021 09:43 CEST Updated version of record -
article html file updated 1 April 2021 09:44 CEST Update -
article xml file uploaded 1 April 2021 09:52 CEST Update -
article xml uploaded. 1 April 2021 09:52 CEST Update -
article pdf uploaded. 1 April 2021 09:52 CEST Updated version of record -
article html file updated 1 April 2021 09:53 CEST Update -
article pdf uploaded. 1 April 2021 09:56 CEST Updated version of record https://www.mdpi.com/2076-393X/9/4/330/pdf
article xml uploaded. 1 April 2021 09:56 CEST Update https://www.mdpi.com/2076-393X/9/4/330/xml
article html file updated 1 April 2021 09:56 CEST Update -
article html file updated 1 April 2021 09:57 CEST Update -
article html file updated 10 April 2021 20:23 CEST Update -
article html file updated 3 August 2021 21:57 CEST Update -
article html file updated 25 July 2022 10:15 CEST Update https://www.mdpi.com/2076-393X/9/4/330/html
Back to TopTop